STAAR Surgical Profit Margin 2010-2025 | STAA

Current and historical gross margin, operating margin and net profit margin for STAAR Surgical (STAA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. STAAR Surgical net profit margin as of March 31, 2025 is -25.46%.
STAAR Surgical Annual Profit Margins
STAAR Surgical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.925B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.592B 21.63
Becton Dickinson (BDX) United States $49.119B 12.16
Cardinal Health (CAH) United States $36.458B 19.09
Straumann Holding AG (SAUHY) Switzerland $20.442B 0.00
Labcorp (LH) United States $20.300B 16.47
Cooper (COO) United States $15.765B 20.91
West Pharmaceutical Services (WST) United States $14.771B 30.96
Align Technology (ALGN) United States $12.380B 24.58
Henry Schein (HSIC) United States $8.721B 14.96
Merit Medical Systems (MMSI) United States $5.637B 27.25
DENTSPLY SIRONA (XRAY) United States $3.083B 9.21
CONMED (CNMD) United States $1.714B 12.82
Lifevantage (LFVN) United States $0.159B 16.44
Pro-Dex (PDEX) United States $0.151B 16.51